Skip to main content
. 2019 Dec 11;21:277. doi: 10.1186/s13075-019-2054-0

Fig. 1.

Fig. 1

Schematic overview of NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC) induced by rituximab, as described previously in a non-malignant experimental setting [24]